By Scientia Professor Gary David Housley

Patents

Housley G, 2024, Electroporation apparatus for providing agents to the cochlea, Europe; France; Germany; UK, Patent No. Europe/France/UK - 3488837; Germany - '602010069586.7

Lovell N; Housley G; Al Abed A; Pinyon J, 2024, Method and system for controlling molecular electrotransfer, Patent No. Japan - 7489116;

Housley G; Cederholm J, 2023, Noise-induced hearing loss susceptibility test method and test apparatus, United States, Patent No. 11850044

Housley G; Crawford E; Pinyon J; Lovell N; Browne C, 2023, Electroporation system for controlled localized therapeutics delivery, New Zealand, Patent No. 737871

Lovell N; Housley G; Crawford E; Pinyon J; Browne C, 2021, Electroporation system for controlled localized therapeutics delivery, Patent No. Australian 2021 pat no.2016282210; China pat no.ZL201680037448.8; India pat no. 365630, Japan pat no. 6987642

Housley G, 2021, Method and apparatus for close-field electroporation, Germany, Patent No. 602014077033.9

Housley G, 2019, Agent provided to the cochlea and cochlear implant, Patent No. 2453856

Housley GD, 2017, Method of providing agents to the cochlea, United States, Patent No. US20140194807; US20170173323; 11026842 (US 2021), http://patft.uspto.gov/netacgi/nph-Parser?Sect2=PTO1&Sect2=HITOFF&p=1&u=/netahtml/PTO/search-bool.html&r=1&f=G&l=50&d=PALL&RefSrch=yes&Query=US-9533138-B2

Back to profile page